Athira Pharma's Alzheimer's drug fails in mid-to-late stage trial

LeonaBio

03/09/2024 21:07

Sept 3 (Reuters) - Athira Pharma  ATHA.O  said on
Tuesday its investigative drug failed to meet the main goal in a
mid-to-late stage trial in patients with mild-to-moderate
Alzheimer's disease.

 (Reporting by Sriparna Roy in Bengaluru; Editing by Shinjini
Ganguli)
 ((Sriparna.Roy@thomsonreuters.com;))